Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)

ClinicalTrials.gov ID: NCT02684006

Public ClinicalTrials.gov record NCT02684006. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 10:11 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A PHASE 3, MULTINATIONAL, RANDOMIZED, OPEN-LABEL, PARALLEL-ARM STUDY OF AVELUMAB (MSB0010718C) IN COMBINATION WITH AXITINIB (INLYTA(REGISTERED)) VERSUS SUNITINIB (SUTENT(REGISTERED)) MONOTHERAPY IN THE FIRST-LINE TREATMENT OF PATIENTS WITH ADVANCED RENAL CELL CARCINOMA

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a phase 3 randomized trial evaluating the anti-tumor activity and safety of avelumab in combination with axitinib and of sunitinib monotherapy, administered as first-line treatment, in patients with advanced renal cell carcinoma

Study identification

NCT ID
NCT02684006
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
886 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 23, 2016 (Actual)
Primary completion
Aug 31, 2023 (Actual)
Completion
Jun 26, 2024 (Actual)
Last update posted
Jul 30, 2025

2016 – 2024

United States locations

U.S. sites
93
U.S. states
21
U.S. cities
44
Facility City State ZIP Site status
Southern Cancer Center Daphne Alabama 36526 —
Southern Cancer Center Mobile Alabama 36607 —
Southern Cancer Center Mobile Alabama 36608 —
Tower Hematology Oncology Medical Group Beverly Hills California 90211 —
City of Hope National Medical Center Duarte California 91010 —
City of Hope Duarte California 91010 —
Keck Hospital of USC Los Angeles California 90033 —
Los Angeles General Medical Center Los Angeles California 90033 —
USC IDS Pharmacy Los Angeles California 90033 —
USC/Norris Comprehensive Cancer Center Los Angeles California 90033 —
Cedars-Sinai Advanced Health Sciences Pavilion Los Angeles California 90048 —
Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute Los Angeles California 90048 —
Cedars-Sinai Los Angeles California 90048 —
Rocky Mountain Cancer Centers Aurora Colorado 80012 —
University of Colorado Cancer Center Anschutz Cancer Pavilion Aurora Colorado 80045 —
University of Colorado Hospital - Clinical Trials Office (CTO) Aurora Colorado 80045 —
University of Colorado Hospital Aurora Colorado 80045 —
Rocky Mountain Cancer Centers Colorado Springs Colorado 80907 —
Georgetown University Medical Center Washington D.C. District of Columbia 20007 —
Moffitt Cancer Center and Research Institute Tampa Florida 33612 —
Emory University Hospital Atlanta Georgia 30322 —
Investigational Drug Service- Emory University Atlanta Georgia 30322 —
The Emory Clinic Atlanta Georgia 30322 —
Winship Cancer Institute, Emory University Atlanta Georgia 30322 —
East Jefferson General Hospital Metairie Louisiana 70006 —
East Jefferson Hematology-Oncology Metairie Physician Service Inc. Metairie Louisiana 70006 —
New England Cancer Specialists Kennebunk Maine 04043 —
New England Cancer Specialists Scarborough Maine 04074 —
New England Cancer Specialists Topsham Maine 04086 —
Oncology Investigational Drug Services- The Sidney Kimmel Cancer Center at Johns Hopkins Hospital Baltimore Maryland 21231 —
Johns Hopkins Hospital Baltimore Maryland 21287 —
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore Maryland 21287 —
Massachusetts General Hospital (MGH) Boston Massachusetts 02114 —
Massachusetts General Hospital Clinical Trials Pharmacy Boston Massachusetts 02114 —
Brigham & Women's Hospital Boston Massachusetts 02115 —
Beth Israel Deaconess Medical Center (BIDMC) Boston Massachusetts 02215 —
Beth Israel Deaconess Medical Center Pharmacy - BIDMC Boston Massachusetts 02215 —
Dana - Farber Cancer Institute Boston Massachusetts 02215 —
Dana-Farber Cancer Institute Boston Massachusetts 02215 —
Baystate Franklin Medical Center Greenfield Massachusetts 01301 —
Mayo Clinic Rochester Minnesota 55905 —
Barnes-Jewish Hospital, Siteman Cancer Center - St. Peters City of Saint Peters Missouri 63376 —
Barnes-Jewish Hospital, Siteman Cancer Center - West County Creve Coeur Missouri 63141 —
Barnes-Jewish Hospital, Siteman Cancer Center St Louis Missouri 63110 —
Washington University Infusion Center Pharmacy St Louis Missouri 63110 —
Washington University School of Medicine St Louis Missouri 63110 —
Barnes-Jewish Hospital, Siteman Cancer Center - South County St Louis Missouri 63129 —
St. Vincent Healthcare Billings Montana 59101 —
Intermountain Health St. Vincent Regional Hospital - Cancer Centers of Montana Billings Montana 59102 —
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 75063 —
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89148 —
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89169 —
New York Oncology Hematology, P.C. Albany New York 12206 —
New York Oncology Hematology, PC Albany New York 12208 —
New York Oncology Hematology, P.C. Clifton Park New York 12065 —
Memorial Sloan Kettering Cancer Center - Investigational Drug Service Pharmacy Long Island City New York 11101 —
Laura & Isaac Perlmutter Cancer Center at NYU Langone New York New York 10016 —
NYU Investigational Pharmacy New York New York 10016 —
NYU Langone Medical Center New York New York 10016 —
MSKCC-Monitoring Suite New York New York 10017 —
Evelyn H. Lauder Breast and Imaging Center New York New York 10065 —
Memorial Sloan Kettering Cancer Center New York New York 10065 —
Sidney Kimmel Center for Prostate and Urologic Cancers New York New York 10065 —
Stony Brook University-Cancer Center Stony Brook New York 11794 —
Stony Brook University Stony Brook New York 11794 —
Novant Health Oncology Specialists Winston-Salem North Carolina 27103 —
Cleveland Clinic Taussig Cancer Center Cleveland Ohio 44106 —
Cleveland Clinic Cleveland Ohio 44195 —
James Cancer Hospital and Solove Research Institute Columbus Ohio 43210 —
The Ohio State University - GU Clinic Columbus Ohio 43210 —
The Ohio State University Columbus Ohio 43210 —
Cancer Care Associates Medical Oncology Allentown Pennsylvania 18104 —
St.Luke's Hospital-Allentown Campus Allentown Pennsylvania 18104 —
Cancer Care Associate Medical Oncology Bethlehem Pennsylvania 18015 —
St. Lukes University Health Network Bethlehem Pennsylvania 18015 —
St.Luke's Cancer Center Anderson Easton Pennsylvania 18045 —
St.Luke's Hospital-Anderson Campus Easton Pennsylvania 18045 —
Hospital of the University of Pennsylvania Philadelphia Pennsylvania 19104 —
Investigational Drug Service, University of Pennsylvania Philadelphia Pennsylvania 19104 —
St.Luke's Quakertown Hospital Quakertown Pennsylvania 18951 —
Henry-Joyce Cancer Clinic Nashville Tennessee 37232 —
Texas Oncology - Baylor Charles A. Sammons Cancer Center Dallas Texas 75246 —
Texas Oncology - Gulf Coast Houston Texas 77024 —
The University of Texas MD Anderson Cancer Center Houston Texas 77030 —
Investigational Product Center (IPC) Irving Texas 75063 —
Investigational Products Center (IPC) Irving Texas 75063 —
Investigational Products Center (lPC) Irving Texas 75063 —
US Oncology Investigational Products Center (IPC) Irving Texas 75063 —
Joe Arrington Cancer Research and Treatment Center Lubbock Texas 79410 —
Rainier Hematology-Oncology, PC Puyallup Washington 98373 —
Fred Hutchinson Cancer Center Seattle Washington 98109 —
University of Washington Medical Center Seattle Washington 98195 —
Northwest Medical Specialties, PLLC Tacoma Washington 98405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 177 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02684006, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 30, 2025 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02684006 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →